EMPOWER-1 and EMPOWER-2 Phase 2 clinical trials did not meet their primary endpoint Emraclidine was well-tolerated with an adverse event profile consistent with ...

Home Depot (NYSE:HD) is set to post third quarter results on Tuesday, before markets open. Wall Street expects the ...

Sibanye Stillwater reaches one-year wage deal with unions at South African gold mines, including 5.5% increase until June ...